Literature DB >> 29229167

Glomerular Diseases in Children.

Scott E Wenderfer1, Joseph P Gaut2.   

Abstract

Unique challenges exist in the diagnosis and treatment of glomerular diseases with their onset during childhood. Mounting evidence supports the notion that earlier onset cases occur due to larger numbers of genetic risk alleles. Nearly all causes of adult-onset glomerulonephritis, nephrotic syndrome, and thrombotic microangiopathy have also been described in children, although the prevalence of specific causes differs. Postinfectious glomerulonephritis, Henoch-Schönlein purpura nephritis, and minimal change disease remain the most common causes of glomerular disease in younger children in the United States and can be diagnosed clinically without need for biopsy. IgA nephropathy is the most common pediatric glomerular disease diagnosed by kidney biopsy and is considered the most common chronic glomerulopathy worldwide. In both developing and developed countries, there is a strong relationship between infectious diseases and nephritis onset or relapse. Although research has led to a better understanding of how to classify and manage glomerular diseases in children, the need for disease-specific biomarkers of activity and chronicity remains a hurdle. The strength of the immune system and the growth and maturation that occurs during adolescence are unique and require age-specific approaches to disease management.
Copyright © 2017 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glomerulonephritis; Hematuria; Nephrotic syndrome; Pediatric; Proteinuria

Mesh:

Year:  2017        PMID: 29229167     DOI: 10.1053/j.ackd.2017.09.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  12 in total

1.  Current management of transition of young people affected by rare renal conditions in the ERKNet.

Authors:  Martin Kreuzer; Jens Drube; Jenny Prüfe; Franz Schaefer; Lars Pape
Journal:  Eur J Hum Genet       Date:  2019-07-30       Impact factor: 4.246

Review 2.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

3.  Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.

Authors:  Eriene-Heidi Sidhom; Choah Kim; Maria Kost-Alimova; May Theng Ting; Keith Keller; Julian Avila-Pacheco; Andrew Jb Watts; Katherine A Vernon; Jamie L Marshall; Estefanía Reyes-Bricio; Matthew Racette; Nicolas Wieder; Giulio Kleiner; Elizabeth J Grinkevich; Fei Chen; Astrid Weins; Clary B Clish; Jillian L Shaw; Catarina M Quinzii; Anna Greka
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 4.  Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.

Authors:  Guo-Xiang Hao; Lin-Lin Song; Dong-Feng Zhang; Le-Qun Su; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

Review 5.  Advances in proteomic profiling of pediatric kidney diseases.

Authors:  Timothy D Cummins; Erik A Korte; Sagar Bhayana; Michael L Merchant; Michelle T Barati; William E Smoyer; Jon B Klein
Journal:  Pediatr Nephrol       Date:  2022-02-26       Impact factor: 3.651

Review 6.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

7.  Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children.

Authors:  Anna E van Beek; Angela Kamp; Simone Kruithof; Ed J Nieuwenhuys; Diana Wouters; Ilse Jongerius; Theo Rispens; Taco W Kuijpers; Kyra A Gelderman
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

8.  Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.

Authors:  Isa F Ashoor; Sarah A Mansfield; Michelle M O'Shaughnessy; Rulan S Parekh; Jarcy Zee; Tetyana L Vasylyeva; Amy J Kogon; Christine B Sethna; Dorey A Glenn; Aftab S Chishti; Donald J Weaver; Margaret E Helmuth; Hilda E Fernandez; Michelle N Rheault
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

9.  Vascular Endothelial Growth Factor (VEGF) and Neopterin Levels in Children with Steroid-sensitive and Steroid-resistant Nephrotic Syndrome.

Authors:  Riska Habriel Ruslie; Darmadi Darmadi; Gontar Alamsyah Siregar
Journal:  Med Arch       Date:  2021-04

10.  Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome.

Authors:  Fengying Wang; Xiaozhong Li; Xueming Zhu; Qing Chen; Lu Jiang; Ziqiang Zhu
Journal:  Biomed Res Int       Date:  2018-05-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.